Model
Edge
Lyell Immunopharma Inc.
0001866154
Filing Type
4
Filing Date
2/11/2026
Updated
2/12/26, 6:46 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership